For both, MFAP4 and fibroscan a clear trend towards higher values in stages F3 and F4 was evident ( Fig. 1 ).
← all excerpts
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients.
2
—
—
The sentences
This observation was statistically highly significant between BL and FU as well as between EoT and FU time points ( Table 3 ).